Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

BEHAVIORAL(1)

DRUG(1)

Patient portal message

1 trial

not_applicable

stanford-university

2 unique interventions2 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Recruiting1

Other1

Role Distribution

Principal Investigator3

PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05295680Phase 2Recruiting

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

Primary Sclerosing Cholangitis

PrincipalinvestigatorStart date: 2023-05-10

NCT04873609Not ApplicableCompleted

Electronic Record Assimilation and Subsequent Eradication of Hepatitis C

Hepatitis CLiver Diseases

PrincipalinvestigatorStart date: 2019-05-01

NCT07631442Enrolling By Invitation

Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis (PBC)

Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Hepatitis C1 Liver Diseases1 Primary Biliary Cholangitis1 Primary Sclerosing Cholangitis1

Affiliations

Stanford University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

11 trials

Shared therapeutic areas:

Liver DiseasesHepatitis C

Similarity Score15%

Theo Heller, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

11 trials

Shared therapeutic areas:

Hepatitis CPrimary Sclerosing Cholangitis

Similarity Score15%

Ed Doo, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

13 trials

Shared therapeutic areas:

Liver DiseasesPrimary Sclerosing Cholangitis

Similarity Score15%

Leina Alrabadi, MD

Stanford University

1 trials

Shared therapeutic areas:

Primary Sclerosing Cholangitis

Worked with same sponsors:

Aparna Goel

Collaborated on 1 trial

Similarity Score14%

Mahmoud Alalfy

Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

14 trials

Shared therapeutic areas:

Hepatitis C

Similarity Score8%

Jeong Min Lee, MD

Seoul National University Hospital

34 trials

Shared therapeutic areas:

Liver Diseases

Similarity Score8%

Xiaolong Qi, MD

LanZhou University

8 trials

Shared therapeutic areas:

Liver Diseases

Similarity Score8%

Shih-Jer Hsu, MD

National Taiwan University Hospital, Yun-Lin Branch

5 trials

Shared therapeutic areas:

Hepatitis C

Similarity Score8%

Wenhong Zhang, MD

Huashan Hospital

4 trials

Shared therapeutic areas:

Liver Diseases

Similarity Score8%

Cheng-Chao Liang, MD

Far Eastern Memorial Hospital

6 trials

Shared therapeutic areas:

Hepatitis C

Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05295680Phase 2PrincipalInvestigator

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

Primary Sclerosing Cholangitis

Recruiting

NCT04873609Not ApplicablePrincipalInvestigator

Electronic Record Assimilation and Subsequent Eradication of Hepatitis C

Hepatitis CLiver Diseases

Completed

NCT07631442PrincipalInvestigator

Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis (PBC)

Enrolling By Invitation

All 3 trials loaded